All In MedTech

Device Trial Radar · NCT07769489

Study to Assess Tolerability of Injecting Larger Volumes (2-5 mL) Subcutaneously at Different Rates: Participant Experience and Acceptance

An Exploratory Study to Investigate Pain Related to Injection of Large Volumes (up to 5mL) Subcutaneously

Last checked: Nov 21, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Aug 17, 2026

Primary completion

Dec 9, 2026

Study completion Dec 11, 2026

Sponsor

Lead sponsor
Novo Nordisk A/SNot on our public-company list
Sponsor type
Industry
First posted
Aug 18, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to investigate the tolerability of different injection/infusion volumes and speed compared to standard practise. The order in which the different volumes and injection speeds will be given to participants will be allocated by chance. Participants will be in this clinical study for about 1 week.

Conditions

  • Healthy Participants

Interventions

  • Syringe PumpDevice

    Device used for delivery of subcutaneous injections and infusions of NaCl solution.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Injection pain rated on a Visual Analogue Scale (VAS)Time frame: 1 minute (±1 minute) from the injection initiation

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Novo Nordisk Clinical Innovation Centre A/S

    Gentofte Municipality, Denmark · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.